Effectiveness of Clopidogrel Resinate(PRegrel) in Patients Undergoing Percutaneous Coronary Intervention Compared With ClopiDogrEl Bisulfate(Plavix).
Phase of Trial: Phase IV
Latest Information Update: 19 Jun 2017
At a glance
- Drugs Clopidogrel (Primary)
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Therapeutic Use
- Acronyms PRIDE
- 15 Jun 2017 Status changed from active, no longer recruiting to completed.
- 15 Jun 2016 Planned End Date changed from 1 Dec 2016 to 1 Feb 2017.
- 15 Jun 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Feb 2017.